JP2020512549A5 - - Google Patents

Download PDF

Info

Publication number
JP2020512549A5
JP2020512549A5 JP2019551363A JP2019551363A JP2020512549A5 JP 2020512549 A5 JP2020512549 A5 JP 2020512549A5 JP 2019551363 A JP2019551363 A JP 2019551363A JP 2019551363 A JP2019551363 A JP 2019551363A JP 2020512549 A5 JP2020512549 A5 JP 2020512549A5
Authority
JP
Japan
Prior art keywords
subject
marker
ctc
cells
panleukocyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019551363A
Other languages
English (en)
Japanese (ja)
Other versions
JP7278595B2 (ja
JP2020512549A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/056760 external-priority patent/WO2018167312A1/en
Publication of JP2020512549A publication Critical patent/JP2020512549A/ja
Publication of JP2020512549A5 publication Critical patent/JP2020512549A5/ja
Application granted granted Critical
Publication of JP7278595B2 publication Critical patent/JP7278595B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019551363A 2017-03-16 2018-03-16 Cd321マーカーの発現に基づく循環腫瘍細胞の検出、定量化、及び/又は単離 Active JP7278595B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17161411 2017-03-16
EP17161411.8 2017-03-16
PCT/EP2018/056760 WO2018167312A1 (en) 2017-03-16 2018-03-16 Detection, quantification and/or isolation of circulating tumor cells based on the expression of cd321 marker

Publications (3)

Publication Number Publication Date
JP2020512549A JP2020512549A (ja) 2020-04-23
JP2020512549A5 true JP2020512549A5 (enExample) 2021-04-08
JP7278595B2 JP7278595B2 (ja) 2023-05-22

Family

ID=58387669

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019551363A Active JP7278595B2 (ja) 2017-03-16 2018-03-16 Cd321マーカーの発現に基づく循環腫瘍細胞の検出、定量化、及び/又は単離

Country Status (8)

Country Link
US (2) US12123877B2 (enExample)
EP (2) EP4235179B1 (enExample)
JP (1) JP7278595B2 (enExample)
KR (1) KR102583603B1 (enExample)
AU (1) AU2018235021B2 (enExample)
CA (1) CA3054915A1 (enExample)
IL (1) IL269315B2 (enExample)
WO (1) WO2018167312A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102019202788A1 (de) 2019-03-01 2020-09-03 Robert Bosch Gmbh Verfahren zum Zählen von Zelltypen oder Zellmarkern in einer Probe, insbesondere in einer Blutprobe
JP2020144054A (ja) * 2019-03-07 2020-09-10 学校法人昭和大学 末梢血循環癌細胞の検出方法及び検出装置
KR102654518B1 (ko) * 2020-05-26 2024-04-04 가톨릭대학교 산학협력단 Lsp1 결핍 t 세포
CN113009135B (zh) * 2021-02-19 2024-04-02 山东省大健康精准医疗产业技术研究院 一种检测cd47的管式磁微粒化学发光免疫定量试剂盒及其制备方法与应用
CA3233047A1 (en) * 2021-09-20 2023-03-23 Droplet Biosciences, Inc. Methods for disease assessment using drain fluid

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
US8980568B2 (en) * 2001-10-11 2015-03-17 Aviva Biosciences Corporation Methods and compositions for detecting non-hematopoietic cells from a blood sample
CN104531529A (zh) 2003-10-31 2015-04-22 维特克公司 用于检测循环肿瘤和内皮细胞的血液测试样机和方法
WO2006130737A1 (en) 2005-06-02 2006-12-07 Immunivest Corporation A method for assessing metastatic carcinomas from circulating endothelial cells and disseminated tumor cells
EP1945817A4 (en) * 2005-11-02 2008-12-10 Univ Michigan Technology Man W MOLECULAR PROFILING OF CANCER
JP2007181462A (ja) * 2005-12-30 2007-07-19 Centocor Inc 細胞の表現型を測定する方法
GB0808413D0 (en) 2008-05-09 2008-06-18 Univ Nottingham Stabilisation of blood cell conjugates
WO2010037134A2 (en) 2008-09-29 2010-04-01 Stemlifeline, Inc. Multi-stage stem cell carcinogenesis
EP2199798A1 (en) 2008-12-18 2010-06-23 Universite Libre De Bruxelles Diagnostic method and kit of circulating tumor cells
EP2455403A1 (en) 2010-11-23 2012-05-23 Pierre Fabre Medicament Homogeneous humanized antibodies against JAM-A that inhibit proliferation
US20130287790A1 (en) 2012-03-30 2013-10-31 The Board Of Trustees Of The Leland Standford Junior University Use of jam-a in diagnosing and treating leukemia
DE112013006579B4 (de) * 2013-02-02 2024-09-05 Duke University Verfahren zum Isolieren zirkulierender Tumorzellen
US10900083B2 (en) 2013-12-20 2021-01-26 The General Hospital Corporation Methods and assays relating to circulating tumor cells
EP3248004B1 (en) 2015-01-21 2020-10-07 Agency For Science, Technology And Research Rare cells and uses thereof

Similar Documents

Publication Publication Date Title
JP2020512549A5 (enExample)
Karimi et al. Tetraspanins distinguish separate extracellular vesicle subpopulations in human serum and plasma–Contributions of platelet extracellular vesicles in plasma samples
Tayebi et al. Exosome purification and analysis using a facile microfluidic hydrodynamic trapping device
Hong et al. Isolation of biologically active and morphologically intact exosomes from plasma of patients with cancer
Hayashi et al. Size-based detection of sarcoma circulating tumor cells and cell clusters
EP2201361B1 (en) Detection of tumor stem cells and tumor cells in epithelial-mesenchymal transition in body fluids of cancer patients
Lukesova et al. High level of Tregs is a positive prognostic marker in patients with HPV‐positive oral and oropharyngeal squamous cell carcinomas
Santos et al. Comparative analysis of innate immune system function in metastatic breast, colorectal, and prostate cancer patients with circulating tumor cells
US10073024B2 (en) Microfluidic device and method for detecting rare cells
CN107075556B (zh) 使用基于磁性和尺寸的分离进行细胞分离的方法和系统
WO2015101163A1 (zh) 抗hla-g的单克隆抗体偶联免疫磁珠在肿瘤细胞分选中的应用
KR20160080815A (ko) 올리고뉴클레오티드 프로브 및 이의 용도
Li et al. Noninvasive Diagnosis and Molecular Phenotyping of Breast Cancer through Microbead‐Assisted Flow Cytometry Detection of Tumor‐Derived Extracellular Vesicles
Kim et al. A microchip filter device incorporating slit arrays and 3-D flow for detection of circulating tumor cells using CAV1-EpCAM conjugated microbeads
JP7225121B2 (ja) 微小胞核酸および/またはタンパク質、並びに腎移植拒絶反応マーカーとしてのその使用
KR102213084B1 (ko) 소변 유래 나노 소포체의 안드로겐 수용체 변이 유전자 검출 방법 및 이를 이용한 체외진단방법
WO2019214063A1 (zh) 一种循环肿瘤细胞的检测方法
Ara et al. Identification and expression of troponin T, a new marker on the surface of cultured tumor endothelial cells by aptamer ligand
Shephard et al. Stroma‐derived extracellular vesicle mRNA signatures inform histological nature of prostate cancer
JP2016519286A (ja) 白血球の枯渇による循環腫瘍細胞の濃縮
CN111351937A (zh) 一种mmr蛋白表达缺失检测试剂盒及其检测方法
Suefuji et al. CXCR3‐positive B cells found at elevated frequency in the peripheral blood of patients with MALT lymphoma are attracted by MIG and belong to the lymphoma clone
Chen et al. A novel cellular senescence gene, SENEX, is involved in peripheral regulatory T cells accumulation in aged urinary bladder cancer
Bu et al. Enhancement of isolation sensitivity for the viable heterogeneous circulating tumor cells swelled by hypo-osmotic pressure
KR101704828B1 (ko) 체액 내 세포밖 소포체의 단백질 또는 유전자 분석을 통한 염증성 질환 진단 방법